Monday, 09 January 2012 16:03

Cytori´s history- the years 2000-05

Article- History untill 2005.

 

Cytori became Cytori on July 11 2005 when the name change from MacroPore Biosurgery became official. Before that date, MacroPore obviously had some history too. That history started in 1997 when the company was founded by Chris Calhoun, Stefan Lemperle and Ralph Holmes. Holmes was a surgeon who left relatively soon thereafter to become CEO of Leonardo MD, a private company developing medical practice software, which he co-founded together with Calhoun

Published in Cytori- Its History
Thursday, 12 January 2012 06:58

Reflections on Cytori- the years 2006-11

MacroPore was from an investors viewpoint- kind of "the dark side" of Cytori- not only because of the failed Medtronic partnership on bio-resorbable implants, but also because of excessive option-plans and failed guidances on revenues etc. The preceeding article "History" was a more objective article and facts driven- what follows is surely also "facts driven", but has definitely a more subjective colour, in view of unrealized potential of the technology that Cytori possesses ( Icall it the "regenerative goldmine"), which potential has not been monetized by the management by any reasonable measurement yardstick sofar- the least as per the present stock price at the end of 2011 of somewhere around 2$.

Published in Cytori- Its History
Wednesday, 29 February 2012 11:45

Cytori- its Partners-past and present-Olympus

Partner Olympus, as a Company, has major issues to resolve after the accounting cover-up scandal emerged. Dont want to comment that here, but you can read all about Woodford, Kikukawa and tobashi in the Wikipedia article- Link here

According to Cytori management this scandal doesnt affect the relationship between Cytori and Olympus at all, which could be partially true, but new strategic developments will hardly be possible, since Olympus probably is like a ship after a fire in the machineroom, after which navigation, power supply etc etc is all non functioning. As we speak- late 2012- CEO Sasa has taken over and the BOD is newly installed. In some aspects the Olympus-Cytori relationship seems to be drawing to an end, but certainly not all. Time will tell. 

Wednesday, 01 February 2012 10:50

Cytori- The Basic science of ADRCs

The basic science of Cytori- Properties of ADRC´s versus other cell sources

This comes straight from the Cytori homepage:

Science & Technology

Cytori Therapeutics’ goal is to provide access to clinical grade Adipose-Derived Stem and Regenerative Cells (ADRCs). ADRCs, sometimes referred to as stromal vascular fraction cells, are a heterogeneous or mixed population of cells found in adipose tissue. This population includes adult stem cells, endothelial progenitor cells, leukocytes, endothelial cells, and vascular smooth muscle cells. Autologous adult stem and regenerative cells are thought to promote healing of scarred or injured tissue.

While we are learning more about the exact mechanisms every day, it is believed that this heterogeneous population of cells influences the local environment via cell-to-cell signaling, immune modulation, and differentiation into other cell types.

Published in Cytori- Its Technology

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites